Alembic Pharma gets USFDA nod for low blood pressure treatment drug

PTI | New Delhi | Updated: 22-01-2021 11:41 IST | Created: 22-01-2021 11:32 IST
Alembic Pharma gets USFDA nod for low blood pressure treatment drug
Representative image Image Credit: ANI

Drug firm Alembic Pharmaceuticals on Friday said it has received approval from the US health regulator for Midodrine Hydrochloride tablets, which are used to treat orthostatic hypotension.

The approved product is therapeutically equivalent to the reference listed drug product ProAmatine tablets of Takeda Pharmaceuticals USA, Inc.

The company has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Midodrine Hydrochloride tablets in the strength of 2.5 mg, 5 mg, and 10 mg, Alembic Pharmaceuticals said in a regulatory filing.

Midodrine Hydrochloride tablets are indicated for the treatment of symptomatic orthostatic hypotension (OH). The drug is used for certain patients who have symptoms of low blood pressure when standing. This condition is also known as orthostatic hypotension.

Quoting IQVIA data, Alembic Pharma said Midodrine Hydrochloride tablets USP 2.5 mg, 5 mg, and 10 mg have an estimated market size of USD 60 million for twelve months ending September 2020.

Alembic now has a total of 138 ANDA approvals (120 final approvals and 18 tentative approvals) from USFDA.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


TRENDING

OPINION / BLOG / INTERVIEW

Why unequal access to coronavirus vaccines is a threat to us all

... ...

India’s love affair with fossil fuels: the path to sustainable development?

... ...

Videos

Latest News

Brazil registers over 1,300 COVID-19 deaths for fifth straight day

Brazil registered 1,386 COVID-19 deaths on Saturday and 61,602 additional cases, according to data released by the nations Health Ministry.The South American country has suffered an enduring second wave since November, and infection rates h...

Rugby-Refereeing decisions spark furious debate after Wales win

Englands coach and captain remained tight-lipped over the controversial decisions that gave Wales two early tries in Saturdays 40-24 Six Nations victory in Cardiff on Saturday but there was no shortage of debate among pundits.Wales scored f...

REUTERS NEWS SCHEDULE 10 p.m. GMT/6:00 a.m. SGT

Saudi Crown Prince Mohammed bin Salman may have been spared direct punishment after a U.S. intelligence report implicated him in the killing of dissident journalist Jamal Khashoggi, but he has not emerged unscathed. NIGERIA-SECURITY Nigeria...

Myanmar's U.N. ambassador vows to fight after junta fired him

Myanmars United Nations envoy in New York vowed to fight on Saturday after the junta fired him for urging countries to use any means necessary to reverse a Feb. 1 coup that ousted the nations elected leader Aung San Suu Kyi.I decided to fig...

Give Feedback